The Switzerland Biosensors Market was valued at USD 446.7 Million in 2024, and is projected to reach USD 764.8 Million by 2030, rising at a CAGR of 9.60%. Various applications of biosensors in medical fields, rising prevalence of diabetes, high demand for miniature diagnostic device, and rapid technological advancements are the key factors driving the growth.
Various government initiatives aimed at development of proteomics and genomics are expected to drive the market for biosensors. Most of the IT companies are also significantly investing in product development. Increasing investments by major IT players such as Infosys, TCS, and IBM are expected to boost the Switzerland biosensors market.
The players in biosensors industry are undertaking various strategies to strengthen their product portfolios and offer diverse technologically advanced and innovative products to their customers. Partnerships, acquisitions, and product launches are the most prominently adopted strategies by the companies to attract more customers. In addition, increasing prevalence of type I and type II diabetes in Switzerland is expected to drive the market over the forecast period. According to the International Diabetes Federation, in 2017, around 547,654 cases of diabetes were reported in Switzerland, which is anticipated to fuel the market growth over the forecast period.
This product will be delivered within 1-3 business days.
Various government initiatives aimed at development of proteomics and genomics are expected to drive the market for biosensors. Most of the IT companies are also significantly investing in product development. Increasing investments by major IT players such as Infosys, TCS, and IBM are expected to boost the Switzerland biosensors market.
The players in biosensors industry are undertaking various strategies to strengthen their product portfolios and offer diverse technologically advanced and innovative products to their customers. Partnerships, acquisitions, and product launches are the most prominently adopted strategies by the companies to attract more customers. In addition, increasing prevalence of type I and type II diabetes in Switzerland is expected to drive the market over the forecast period. According to the International Diabetes Federation, in 2017, around 547,654 cases of diabetes were reported in Switzerland, which is anticipated to fuel the market growth over the forecast period.
Switzerland Biosensors Market Report Highlights
- On the basis of technology, the electrochemical segment held the largest revenue share of over 71.5% in 2024 owing to their widespread applications for quantification and analysis in biochemical and biological processes.
- Biosensors in agriculture industry is expected to witness the fastest CAGR over the forecast period owing to the rising demand for sensor technology in the field.
- The PoC testing segment held the largest revenue share at 48.8% in 2024. Increasing demand for portable and rapid point-of-care diagnostic devices that can be used outside conventional laboratories is one of the key drivers.
- Prominent players present in the Switzerland biosensors market are Abbott, Biosensor International Group, Ltd., Bayer AG, Lucentix SA, Xsensio, and Sensirion AG Switzerland, Innovative Sensor Technology (IST) AG.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Switzerland Biosensors Market Variables, Trends & Scope
Chapter 4. Switzerland Biosensors Market: Technology Estimates & Trend Analysis
Chapter 5. Switzerland Biosensors Market: Application Estimates & Trend Analysis
Chapter 6. Switzerland Biosensors Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Switzerland Biosensors market report include:- Abbott Laboratories
- Biosensors International Group Ltd
- Bayer AG
- Xsensio
- Lucentix SA
- Sensirion AG Switzerland
- Innovative Sensor Technology (IST) AG
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 90 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 446.7 Million |
Forecasted Market Value ( USD | $ 764.8 Million |
Compound Annual Growth Rate | 9.6% |
Regions Covered | Switzerland |
No. of Companies Mentioned | 8 |